NEW PERSPECTIVES OF DIPYRIDAMOL USAGE IN TREATMENT OF CORONARY HEART DISEASE

QR Code

NEW PERSPECTIVES OF DIPYRIDAMOL USAGE IN TREATMENT OF CORONARY HEART DISEASE

There is a great number of coronary patients to whom traditional methods of myocardium revascularization are not indicated. Addition of dipyridamol to traditional antianginal treatment promotes improvement of clinical features of the disease and decreased functional class of angina in coronary patie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Y. I. Buziashvili, S. T. Matskeplishvili, E. U. Asymbekova, I. H. Hapiy, T. V. Burduli, O. S. Sherbakova, V. I. Buvaltsev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2003-08-01
Series:	Российский кардиологический журнал
Subjects:	coronary heart disease (chd) angiogenesis stress echo dipyridamol
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1774
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Topic diagnostics of coronary pathology in coronary heart disease patients by contrast stress echocardiography with dipyridamole
by: S. T. Matskeplishvili, et al.
Published: (2005-10-01)

DOSE-DEPENDENT EFFECTS OF DIPYRIDAMOLE IN PATIENTS WITH CONGESTIVE HEART FAILURE
by: M. P. Savenkov, et al.
Published: (2001-02-01)

Effects of adenosine and dipyridamole on serum levels of some biochemical markers in rabbits: Running title: Biochemical effects of adenosine and dipyridamole
by: Taghreed Hazem Saber Alfakje, et al.
Published: (2022-12-01)

Dipyridamole stress echocardiography combined with pair-wise bicycle stress test and transesophageal atrial stimulation in coronary heart disease diagnostics
by: A. Yu. Vasilyev, et al.
Published: (2005-08-01)

CLINICAL BASIS OF DIPYRIDAMOL USE IN OBSTETRIC PRACTICE
by: S. V. Akinshina, et al.
Published: (2017-08-01)

PLACENTAL INSUFFICIENCY IN COMPLICATED PREGNANCY AND POSSIBILITY OF TREATMENT WITH DIPYRIDAMOLE
by: A. D. Makatsariya, et al.
Published: (2017-03-01)

RELATIONSHIP BETWEEN CHARACTERISTIC PATIENT WITH RECURRENT CORONARY HEART DISEASE
by: Sri Haryuni, et al.
Published: (2025-05-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine
by: M. M. Dolzhenko, et al.
Published: (2025-06-01)

Bone marrow stem cell treatment in heart failure patients
by: Yu. I. Buziashvili, et al.
Published: (2005-10-01)

Aspirin effectiveness in patients with rheumatoid arthritis and coronary heart disease who receive non-steroidal anti-inflammatory drugs
by: T. V. Kropotina, et al.
Published: (2013-04-01)

THE ASSESSMENT OF PRETEST PROBABILITY IN OBSTRUCTIVE CORONARY LESION DIAGNOSTICS: UNRESOLVED ISSUES
by: A. N. Sumin
Published: (2017-12-01)

GENOTYPE -786CC OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE NOS3 AS A FACTOR OF ADVERSE CORONARY HEART DISEASE COURSE AND INCREASED ON-TREATMENT PLATELET AGGREGATION
by: E. F. Muslimova, et al.
Published: (2017-11-01)

Right heart remodeling in coronary heat disease: clinico-pathophysiological correlations
by: N. S. Buslenko, et al.
Published: (2005-10-01)

Feasibility of coronary flow velocity reserve during semi-supine exercise echocardiography: a single center study of 3,014 patients
by: Angela Zagatina, et al.
Published: (2024-02-01)

A rare case of successful recanalization of the anterior interventricular artery through a mammary-coronary graft in a patient 15 years after coronary artery bypass grafting
by: M. A. Alekseeva, et al.
Published: (2018-12-01)

INFLUENCE OF BACTERIAL FACTORS ON DETERIORATION OF UTEROPLACENTAL PERFUSION
by: V. A. Kaptilnyy, et al.
Published: (2016-09-01)

ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
by: V. E. Oleynikov, et al.
Published: (2015-11-01)

BDNF/TrkB signaling in stable coronary artery disease
by: O. V. Atamas, et al.
Published: (2023-12-01)

Extemal counter-pulsation effects on left ventricular myocardial perfusion in patients with coronary heart disease
by: I. V. Sergienko, et al.
Published: (2008-12-01)

Development and Validation of the CHDSI Questionnaire: A New Tool for Measuring Disease-Specific Quality of Life in Children and Adolescents with Congenital Heart Defects
by: Paul C. Helm, et al.
Published: (2025-07-01)

Original method of external muscular counter-pulsation in coronary heart disease patients at cardiosurgery clinic
by: L. A. Bokeriya, et al.
Published: (2005-10-01)

Normal ultrasound measurements of atria and heart ventricles of 25–64 years old people
by: A. K. Shadmanov, et al.
Published: (2013-06-01)

Diagnostic significance of magnetic resonance imaging for myocardial damage of various genesis
by: E. V. Belovolova, et al.
Published: (2018-10-01)

Production of angiogenesis mediators and the structure of the vascular wall in the heart in ischemic cardiomyopathy
by: S. P. Chumakova, et al.
Published: (2024-01-01)

Coronary vasospasm induced by aminophylline after negative dipyridamole stress echocardiography: a case report
by: Lauro Cortigiani, et al.
Published: (2025-07-01)

MORTALITAS OPERASI JANTUNG CORONARY ARTERY BYPASS GRAFT DI RSUP DR KARIADI SEMARANG PERIODE JANUARI 2014 - DESEMBER 2014
by: Gina Amalia Harahap, et al.
Published: (2016-04-01)

CORONARY ANGIOGENESIS: DIPYRIDAMOLE IS BACK ON THE STAGE
by: F. Lombardi, et al.
Published: (2001-08-01)

CORONARY ANGIOGENESIS: DIPYRIDAMOLE IS BACK ON THE STAGE
by: F. Lombardi, et al.
Published: (2001-10-01)

THE DIFFERENTIATED LIPID-LOWERING THERAPY IN WOMEN WITH CORONARY HEART DISEASE IN MENOPAUSE
by: N. A. Manak, et al.
Published: (2012-03-01)

The simulation of spin echo excitation by pulses with arbitrary modulation
by: S. A. Baruzdin
Published: (2015-02-01)

SIGNIFICANCE OF M1 AND M2 POLARIZATION OF MONOCYTES-MACROPHAGES IN THE BLOOD FOR ATHEROSCLEROSIS RISK ASSESSMENT IN TYPE 2 DIABETES COMPARING WITH CORONARY HEART DISEASE
by: К. О. Galstyan, et al.
Published: (2017-12-01)

COMPLIANCE TO CLINICIAN PRESCRIPTIONS IN ISCHEMIC HEART DISEASE PATIENTS (BY THE DATA FROM OUTPATIENT REGISTRY PROFILE)
by: Yu. V. Lukina, et al.
Published: (2017-03-01)

The Distinction of Inhibiting Factors among Patients who Actively and Inactively Participate in Phase II Cardiac Rehabilitation
by: Megalita Dwika Stevani, et al.
Published: (2018-08-01)

Various doses of statins and coronary angiogenesis in patients with coronary heart disease
by: I. V. Sergienko, et al.
Published: (2009-10-01)

Angiogenic properties of adipose tissue-derived multipotent mesenchymal stromal cells in patients with coronary heart disease
by: N. A. Dzhoyashvili, et al.
Published: (2013-10-01)

ANALYSIS OF THE TRADITIONAL RISK FACTORS INFLUENCE ON DEVELOPMENT OF ISCHEMIC HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2017-06-01)

Case Report: Challenges in diagnosing Kawasaki disease in children under 3 months of age: a case series report
by: Duc Long Phi, et al.
Published: (2025-07-01)

TACTICS FEATURES OF CONDUCTING AND CHOOSING SPECIFIC THERAPY FOR ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE
by: O. A. Arkhipova, et al.
Published: (2018-03-01)

New perspectives in coronary heart disease management
by: V. I. Makolkin
Published: (2005-02-01)